Mice Model Market Outlook:
The global mice model market is experiencing a major growth, and will grow considerably in next few years. A mice model is a laboratory model used for research and development of human physiology biomedical science or disease. It is used for studying the complex diseases such as hypertension and atherosclerosis. The major reason mice are vital in research is its 95% genetic similarity with the humans.
COVID-19 scenario analysis:
- The market demand for COVID-19 mice models is increasing, especially for humanized ACE2 (hACE2) mice, which express human ACE2 in the airway and other epithelia and develop a lethal SARS-CoV infection.
- Surge in the demand of vaccines has increased research and development during Covid-19 due to increase in cases each day across the globe. For instance, many researches are at preclinical phase across the globe such as according to the WHO, more than 20 vaccines are being developed across the globe for COVID-19.
- The disruption of supply chain has limit mice model providers to get readymade mice model to meet the surging demand of populations. Further, due to implementation of the lockdown the normal working of research institution has slowed down.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Prevalence of chronic diseases and growing demand for mice model in cancer research for genetic understanding. In addition, strategies such as partnerships and collaborations by major industry players such as Charles River, Envigo, genOway, Transviragen Inc., etc. Further growing applications of mice model for various research and ongoing research and development activities in pharmaceutical industry are major factor driving the growth of mice model market. However, Regulations and laws for the ethical use of animals in research hamper the market growth. Conversely, CRISPR, a gene editing technology and surge in demand of mice model research for vaccine against covid-19 is expected to propel the growth of mice models market in the pandemic period.
The global mice model market trends are as follows:
New product launches and collaborations to flourish the market
The launches due to rise in demand of therapeutics and constant innovations has tremendously driven the market growth. For instance, in July 2019, Taconic Biosciences has launched its 1st commercially produced NASH diet-induced (nonalcoholic steatohepatitis) mice model. Further, in December 2018, the Jackson Laboratories has developed a new mouse population that would model both human Alzheimer’s and human genetic diversity at same time.
Surge in usage in medical applications
The mice models have wider range of application in understanding the genome of many complex diseases in biomedical engineering. These are widely used in many research institutes across the globe for diseases such as Alzheimer’s, diabetes, cancer, and Covid-19. The research and demand of vaccine preparation of Covid-19 has gained the maximum attention towards the mice models market.
Key benefits of the report:
- This study presents the analytical depiction of the global mice model industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global mice model market share.
- The current market is quantitatively analyzed to highlight the global mice model market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides detailed global mice model market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Mice model Market research report:
- What are the leading market players active in the mice model market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Key Market Segments
- By Type
- Inbred Mice
- Genetically Engineered Mice
- Hybrid Mice
- Outbred Mice
- Others
- By Services
- Breeding
- Quarantine
- Rederivation
- Model In-Licensing
- Genetic Testing
- Other Services
- By Therapeutic Area
- Oncology
- Immunology and Inflammation
- Diabetes
- Cardiovascular
- Neurobiology
- Other Diseases
- By Technology
- CRISPR/Cas9
- Embryonic Stem Cell Injection
- Microinjection
- Somatic Cell Nuclear Transfer
- Other Technologies
- By Mice Care Products
- Cages
- Feed
- Bedding
- Others
- By End User
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Others
- By Region
- North America
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- International, Inc
- Charles River Laboratories
- genOway
- The Jackson Laboratory
- Laboratory Corporation of America Holdings
- Trans Genic Inc
- Ingenious Targeting Laboratory
- Horizon Discovery Group plc
- Envigo
- Taconic Biosciences, Inc
Other Players